MaxCyte, Inc. Share Price
MXCTMaxCyte, Inc. Stock Performance
Open $0.74 | Prev. Close $0.73 | Circuit Range N/A |
Day Range $0.70 - $0.74 | Year Range $0.70 - $4.32 | Volume 28,993 |
Average Traded $0.72 |
MaxCyte, Inc. Share Price Chart
About MaxCyte, Inc.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
MaxCyte, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
13-Feb-26 | $0.74 | $0.72 | +0.00% |
13-Feb-26 | $0.74 | $0.72 | -2.57% |
12-Feb-26 | $0.73 | $0.74 | +1.23% |
11-Feb-26 | $0.78 | $0.73 | -6.05% |
10-Feb-26 | $0.79 | $0.78 | -2.88% |
09-Feb-26 | $0.79 | $0.80 | -1.11% |
06-Feb-26 | $0.81 | $0.81 | +0.00% |